Indication: Myelofibrosis
Title: A Study to Evaluate Safety and Efficacy of Selinexor in Combination With Ruxolitinib in Participants With Myelofibrosis
Drug: Selinexor

Please Visit clinicaltrials.gov for more information about this study.

Phase 1Phase 2Phase 3Commercial
Phase 1
Phase 2
Phase 3
Commercial